Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India

Krishna Pandey; V N R Das; Dharmendra Singh; Sushmita Das; C S Lal; N Verma; S Bimal; R K Topno; N A Siddiqui; R B Verma; P K Sinha; Pradeep Das

doi:10.1128/JCM.05966-11

Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India

J Clin Microbiol. 2012 Apr;50(4):1478-9. doi: 10.1128/JCM.05966-11. Epub 2012 Jan 25.

Authors

Krishna Pandey¹, V N R Das, Dharmendra Singh, Sushmita Das, C S Lal, N Verma, S Bimal, R K Topno, N A Siddiqui, R B Verma, P K Sinha, Pradeep Das

Affiliation

¹ Rajendra Memorial Research Institute of Medical Sciences (Indian Council of Medical Research), Agamkuan, Patna, Bihar, India. drkrishnapandey@yahoo.com

Abstract

Post kala-azar dermal leishmaniasis (PKDL) is a skin manifestation that usually develops after treatment of visceral leishmaniasis (VL), a major public health problem in India. The diagnosis and management of PKDL is complex. This is the first case report from India in which PKDL occurred after paromomycin treatment for VL in an Indian patient.

Publication types

Case Reports

MeSH terms

Adult
Antiprotozoal Agents / administration & dosage*
Female
Humans
Leishmania donovani*
Leishmaniasis, Cutaneous / complications
Leishmaniasis, Cutaneous / diagnosis*
Leishmaniasis, Cutaneous / parasitology
Leishmaniasis, Cutaneous / prevention & control
Leishmaniasis, Visceral / complications
Leishmaniasis, Visceral / drug therapy*
Leishmaniasis, Visceral / parasitology
Paromomycin / administration & dosage*
Secondary Prevention

Substances

Antiprotozoal Agents
Paromomycin